Active Ingredient: DOXORUBICIN HYDROCHLORIDE
Proprietary Name: DOXIL (LIPOSOMAL)
Dosage Form; Route of Administration: INJECTABLE, LIPOSOMAL; INJECTION
Strength: 20MG/10ML (2MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N050718
Product Number: 001
Approval Date: Nov 17, 1995
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
